NCT05282914View on ClinicalTrials.gov

A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

April 14, 2021

Study Completion Date

September 1, 2021

Conditions
GERD
Interventions
DRUG

administration of UI058

UI058 1Tab/day for 7days

DRUG

administration of UIC202004

UIC202004 1Tab/day for 7days

Trial Locations (1)

KS001

Chungbuk national university hospital, Cheongju-si

All Listed Sponsors
lead

Korea United Pharm. Inc.

INDUSTRY

NCT05282914 - A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects | Biotech Hunter | Biotech Hunter